Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 19 (10), 50

Medical Marijuana and Chronic Pain: A Review of Basic Science and Clinical Evidence

Affiliations
Review

Medical Marijuana and Chronic Pain: A Review of Basic Science and Clinical Evidence

Bjorn Jensen et al. Curr Pain Headache Rep.

Abstract

Cannabinoid compounds include phytocannabinoids, endocannabinoids, and synthetics. The two primary phytocannabinoids are delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), with CB1 receptors in the brain and peripheral tissue and CB2 receptors in the immune and hematopoietic systems. The route of delivery of cannabis is important as the bioavailability and metabolism are very different for smoking versus oral/sublingual routes. Gold standard clinical trials are limited; however, some studies have thus far shown evidence to support the use of cannabinoids for some cancer, neuropathic, spasticity, acute pain, and chronic pain conditions.

Similar articles

See all similar articles

Cited by 21 PubMed Central articles

See all "Cited by" articles

References

    1. J Pharmacol Exp Ther. 1988 Dec;247(3):1046-51 - PubMed
    1. Arch Intern Med. 2007 Feb 12;167(3):221-8 - PubMed
    1. Clin Pharmacol Ther. 1978 Aug;24(2):223-7 - PubMed
    1. Addiction. 2002 Mar;97(3):243-7 - PubMed
    1. Clin Pharmacol Ther. 1977 Jan;21(1):26-33 - PubMed

MeSH terms

LinkOut - more resources

Feedback